GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3601 - 3625 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 1 10 moderate
G08520NM
430
IgA Patient 1 22 moderate
G08520NM
394
IgA Patient 1 6 moderate
G08520NM
409
IgG Patient 1 10 moderate
G08520NM
24
IgG Patient 1 22 moderate
G08520NM
38
IgG Patient 1 6 moderate
G08520NM
24
IgM Patient 1 10 moderate
G08520NM
46
IgM Patient 1 22 moderate
G08520NM
221
IgM Patient 1 6 moderate
G08520NM
45
IgA Patient 2 15 mild
G08520NM
381
IgA Patient 2 24 mild
G08520NM
437
IgG Patient 2 15 mild
G08520NM
36
IgG Patient 2 24 mild
G08520NM
37
IgM Patient 2 15 mild
G08520NM
177
IgM Patient 2 24 mild
G08520NM
179
IgA Patient 2 3 mild
G08520NM
432
IgG Patient 2 3 mild
G08520NM
43
IgM Patient 2 3 mild
G08520NM
235
IgA Patient 3 -180 mild
G08520NM
257
IgA Patient 3 11 mild
G08520NM
432
IgG Patient 3 -180 mild
G08520NM
58
IgG Patient 3 11 mild
G08520NM
35
IgM Patient 3 -180 mild
G08520NM
105
IgA Patient 3 4 mild
G08520NM
461
IgG Patient 3 4 mild
G08520NM
38

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024